Viking Therapeutics Stock Has 72% Upside, According to 1 Wall Street Analyst
Investors looking for stocks that can make dramatic gains in a short time frame might want to turn their attention to the biopharmaceutical industry. Shares of Viking Therapeutics (NASDAQ: VKTX) have already risen more than four-fold this year.
Despite Viking's rapid ascent Oppenheimer analyst, Jay Olson thinks it can climb much higher over the next 12 months. Olson recently raised his price target for Viking Therapeutics to $138 from $116 and kept an outperform rating on the stock.
Oppenheimer's raised price target is a response to positive clinical trial results for an experimental weight-management therapy Viking Therapeutics is developing named VK2735.
Source Fool.com
Viking Therapeutics Inc Stock
€57.40
0.320%
Our community is currently high on Viking Therapeutics Inc with 5 Buy predictions and 0 Sell predictions.
With a target price of 100 € there is a hugely positive potential of 74.22% for Viking Therapeutics Inc compared to the current price of 57.4 €.
